All methods were carried out in accordance with relevant guidelines and regulations
Retatrutide is an investigational triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, enhancing insulin secretion, suppressing appetite, increasing energy expenditure, and promoting hepatic fat oxidation
To view a copy of this licence, visit About this article Cite this article Fornasari, D.M.M
Avoid skipping doses to maintain stable blood sugar levels
Additionally, it inhibits tyrosinase to reduce melanin production, brightens skin, and protects mitochondria, ensuring energy efficiency and combating aging-related oxidative stress